Klabatsa A - Search Results

1

Expression and prognostic significance of hypoxia-inducible factor 1alpha (HIF-1alpha) in malignant pleural mesothelioma (MPM).

Klabatsa A, Sheaff MT, Steele JP, Evans MT, Rudd RM, Fennell DA. Klabatsa A, et al. Lung Cancer. 2006 Jan;51(1):53-9. doi: 10.1016/j.lungcan.2005.07.010. Epub 2005 Sep 16. Lung Cancer. 2006. PMID: 16169121

2

Prognostic factors in mesothelioma.

Steele JP, Klabatsa A, Fennell DA, Palläska A, Sheaff MT, Evans MT, Shamash J, Rudd RM. Steele JP, et al. Among authors: klabatsa a. Lung Cancer. 2005 Jul;49 Suppl 1:S49-52. doi: 10.1016/j.lungcan.2005.03.009. Lung Cancer. 2005. PMID: 15894403

3

In vivo loss of expression of argininosuccinate synthetase in malignant pleural mesothelioma is a biomarker for susceptibility to arginine depletion.

Szlosarek PW, Klabatsa A, Pallaska A, Sheaff M, Smith P, Crook T, Grimshaw MJ, Steele JP, Rudd RM, Balkwill FR, Fennell DA. Szlosarek PW, et al. Among authors: klabatsa a. Clin Cancer Res. 2006 Dec 1;12(23):7126-31. doi: 10.1158/1078-0432.CCR-06-1101. Clin Cancer Res. 2006. PMID: 17145837

4

Chemotherapy options and new advances in malignant pleural mesothelioma.

Steele JP, Klabatsa A. Steele JP, et al. Among authors: klabatsa a. Ann Oncol. 2005 Mar;16(3):345-51. doi: 10.1093/annonc/mdi094. Epub 2005 Jan 27. Ann Oncol. 2005. PMID: 15677623 Free article. Review.

5

Diffuse pleural mesothelioma with epithelioid and angiosarcomatous components--a hitherto undescribed pattern of differentiation.

Klabatsa A, Nicholson AG, Dulay K, Rudd RM, Sheaff MT. Klabatsa A, et al. Histopathology. 2012 Jun;60(7):1164-6. doi: 10.1111/j.1365-2559.2012.04220.x. Epub 2012 Mar 2. Histopathology. 2012. PMID: 22385410 No abstract available.

6

BAK and NOXA are critical determinants of mitochondrial apoptosis induced by bortezomib in mesothelioma.

Busacca S, Chacko AD, Klabatsa A, Arthur K, Sheaff M, Barbone D, Mutti L, Gunasekharan VK, Gorski JJ, El-Tanani M, Broaddus VC, Gaudino G, Fennell DA. Busacca S, et al. Among authors: klabatsa a. PLoS One. 2013 Jun 7;8(6):e65489. doi: 10.1371/journal.pone.0065489. Print 2013. PLoS One. 2013. PMID: 23762382 Free PMC article.

7

Resistance to HSP90 inhibition involving loss of MCL1 addiction.

Busacca S, Law EW, Powley IR, Proia DA, Sequeira M, Le Quesne J, Klabatsa A, Edwards JM, Matchett KB, Luo JL, Pringle JH, El-Tanani M, MacFarlane M, Fennell DA. Busacca S, et al. Among authors: klabatsa a. Oncogene. 2016 Mar 24;35(12):1483-92. doi: 10.1038/onc.2015.213. Epub 2015 Jun 22. Oncogene. 2016. PMID: 26096930 Free PMC article.

8

Imaging in pleural mesothelioma: a review of the 11th International Conference of the International Mesothelioma Interest Group.

Armato SG 3rd, Labby ZE, Coolen J, Klabatsa A, Feigen M, Persigehl T, Gill RR. Armato SG 3rd, et al. Among authors: klabatsa a. Lung Cancer. 2013 Nov;82(2):190-6. doi: 10.1016/j.lungcan.2013.08.005. Epub 2013 Aug 15. Lung Cancer. 2013. PMID: 24018024 Review.

9

The association of 18F-FDG PET/CT parameters with survival in malignant pleural mesothelioma.

Klabatsa A, Chicklore S, Barrington SF, Goh V, Lang-Lazdunski L, Cook GJ. Klabatsa A, et al. Eur J Nucl Med Mol Imaging. 2014 Feb;41(2):276-82. doi: 10.1007/s00259-013-2561-1. Epub 2013 Sep 21. Eur J Nucl Med Mol Imaging. 2014. PMID: 24057459

10

Autophagy Correlates with the Therapeutic Responsiveness of Malignant Pleural Mesothelioma in 3D Models.

Barbone D, Follo C, Echeverry N, Gerbaudo VH, Klabatsa A, Bueno R, Felley-Bosco E, Broaddus VC. Barbone D, et al. Among authors: klabatsa a. PLoS One. 2015 Aug 18;10(8):e0134825. doi: 10.1371/journal.pone.0134825. eCollection 2015. PLoS One. 2015. PMID: 26284517 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page